Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome

Publisher： John Wiley & Sons Inc

E-ISSN： 1469-0705|51|1|126-133

ISSN： 0960-7692

Source： ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol.51, Iss.1, 2018-01, pp. : 126-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Re: Serum vascular endothelial growth factor levels following luteal gonadotrophin‐releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome

By  

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 4, 2015-03 ,pp. : 585-585

John Wiley & Sons Inc

Access to resources Recommend Favorite

Authors’ reply re: Serum vascular endothelial growth factor levels following luteal gonadotrophin‐releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome

By  

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 4, 2015-03 ,pp. : 585-586

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevention and Management of Ovarian Hyperstimulation Syndrome

By  

Current Women's Health Reviews, Vol. 6, Iss. 2, 2010-05 ,pp. : 130-145

Bentham Science Publishers

Access to resources Recommend Favorite

Randomized trial of combined cabergoline and coasting in preventing ovarian hyperstimulation syndrome during in vitro fertilization/intracytoplasmic sperm injection cycles

By  

International Federation of Gynecology and Obstetrics, Vol. 140, Iss. 2, 2018-02 ,pp. : 217-222

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention

By  

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 45, Iss. 4, 2015-04 ,pp. : 377-393

John Wiley & Sons Inc

Access to resources Recommend Favorite